These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

407 related items for PubMed ID: 23329671

  • 1. Feasibility and comparison of visual acuity testing methods in children with neurofibromatosis type 1 and/or optic pathway gliomas.
    Avery RA, Bouffet E, Packer RJ, Reginald A.
    Invest Ophthalmol Vis Sci; 2013 Feb 05; 54(2):1034-8. PubMed ID: 23329671
    [Abstract] [Full Text] [Related]

  • 2. Screening and diagnosis of optic pathway gliomas in children with neurofibromatosis type 1 by using sweep visual evoked potentials.
    Chang BC, Mirabella G, Yagev R, Banh M, Mezer E, Parkin PC, Westall CA, Buncic JR.
    Invest Ophthalmol Vis Sci; 2007 Jun 05; 48(6):2895-902. PubMed ID: 17525226
    [Abstract] [Full Text] [Related]

  • 3. Optic pathway gliomas in patients with neurofibromatosis type 1: follow-up of 44 patients.
    Segal L, Darvish-Zargar M, Dilenge ME, Ortenberg J, Polomeno RC.
    J AAPOS; 2010 Apr 05; 14(2):155-8. PubMed ID: 20451859
    [Abstract] [Full Text] [Related]

  • 4. Visual outcomes after chemotherapy for optic pathway glioma in children with and without neurofibromatosis type 1: results of the International Society of Paediatric Oncology (SIOP) Low-Grade Glioma 2004 trial UK cohort.
    Falzon K, Drimtzias E, Picton S, Simmons I.
    Br J Ophthalmol; 2018 Oct 05; 102(10):1367-1371. PubMed ID: 29343527
    [Abstract] [Full Text] [Related]

  • 5. [Long-term outcome of gliomas of the visual pathway in type 1 neurofibromatosis].
    Schröder S, Baumann-Schröder U, Hazim W, Haase W, Mautner VF.
    Klin Monbl Augenheilkd; 1999 Dec 05; 215(6):349-54. PubMed ID: 10637799
    [Abstract] [Full Text] [Related]

  • 6. Visual acuity of children treated with chemotherapy for optic pathway gliomas.
    Kalin-Hajdu E, Décarie JC, Marzouki M, Carret AS, Ospina LH.
    Pediatr Blood Cancer; 2014 Feb 05; 61(2):223-7. PubMed ID: 23956233
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Visual Acuity Results Between ATS-HOTV and E-ETDRS Testing Methods in Children With Optic Pathway Gliomas.
    Avery RA, Go C, Fisher MJ, Liu GT, Garcia A, Richter M, McGeehan B, Quinn GE, Ying GS.
    Transl Vis Sci Technol; 2022 Mar 02; 11(3):10. PubMed ID: 35262649
    [Abstract] [Full Text] [Related]

  • 8. Fractional anisotropy of the optic radiations is associated with visual acuity loss in optic pathway gliomas of neurofibromatosis type 1.
    de Blank PM, Berman JI, Liu GT, Roberts TP, Fisher MJ.
    Neuro Oncol; 2013 Aug 02; 15(8):1088-95. PubMed ID: 23658320
    [Abstract] [Full Text] [Related]

  • 9. Visual loss in orbitofacial neurofibromatosis type 1.
    Oystreck DT, Morales J, Chaudhry I, Alorainy IA, Elkhamary SM, Pasha TM, Bosley TM.
    Ophthalmology; 2012 Oct 02; 119(10):2168-73. PubMed ID: 22709421
    [Abstract] [Full Text] [Related]

  • 10. Neurofibromatosis type 1 and optic pathway gliomas: follow-up of 54 patients.
    Thiagalingam S, Flaherty M, Billson F, North K.
    Ophthalmology; 2004 Mar 02; 111(3):568-77. PubMed ID: 15019338
    [Abstract] [Full Text] [Related]

  • 11. Can screening for optic nerve gliomas in patients with neurofibromatosis type I be performed with visual-evoked potential testing?
    Wolsey DH, Larson SA, Creel D, Hoffman R.
    J AAPOS; 2006 Aug 02; 10(4):307-11. PubMed ID: 16935228
    [Abstract] [Full Text] [Related]

  • 12. Optic Pathway Gliomas in Neurofibromatosis Type 1: An Update: Surveillance, Treatment Indications, and Biomarkers of Vision.
    de Blank PMK, Fisher MJ, Liu GT, Gutmann DH, Listernick R, Ferner RE, Avery RA.
    J Neuroophthalmol; 2017 Sep 02; 37 Suppl 1(Suppl 1):S23-S32. PubMed ID: 28806346
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the amblyopia treatment study HOTV and electronic-early treatment of diabetic retinopathy study visual acuity protocols in children aged 5 to 12 years.
    Rice ML, Leske DA, Holmes JM.
    Am J Ophthalmol; 2004 Feb 02; 137(2):278-82. PubMed ID: 14962417
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Normative visual acuity in infants and preschool-aged children in Sydney.
    Leone JF, Mitchell P, Kifley A, Rose KA, Sydney Childhood Eye Studies.
    Acta Ophthalmol; 2014 Nov 02; 92(7):e521-9. PubMed ID: 24606232
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Visual outcome of a cohort of children with neurofibromatosis type 1 and optic pathway glioma followed by a pediatric neuro-oncology program.
    Dalla Via P, Opocher E, Pinello ML, Calderone M, Viscardi E, Clementi M, Battistella PA, Laverda AM, Da Dalt L, Perilongo G.
    Neuro Oncol; 2007 Oct 02; 9(4):430-7. PubMed ID: 17704361
    [Abstract] [Full Text] [Related]

  • 19. Optic pathway glioma: long-term visual outcome in children without neurofibromatosis type-1.
    Campagna M, Opocher E, Viscardi E, Calderone M, Severino SM, Cermakova I, Perilongo G.
    Pediatr Blood Cancer; 2010 Dec 01; 55(6):1083-8. PubMed ID: 20979170
    [Abstract] [Full Text] [Related]

  • 20. Long-term visual outcomes of optic pathway gliomas in pediatric patients without neurofibromatosis type 1.
    Wan MJ, Ullrich NJ, Manley PE, Kieran MW, Goumnerova LC, Heidary G.
    J Neurooncol; 2016 Aug 01; 129(1):173-8. PubMed ID: 27311725
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.